PA
PRCT icon

Parallel Advisors’s Procept Biorobotics PRCT Stock Holding History

Parallel Advisors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$73.8K Buy
2,950
+2,409
+445% +$67.9K ﹤0.01% 1764
2025
Q4 		$17K Sell
541
-410
-43% -$13.6K ﹤0.01% 2374
2025
Q3 		$33.9K Sell
951
-59
-6% -$2.69K ﹤0.01% 1994
2025
Q2 		$58.2K Sell
1,010
-10
-1% -$565 ﹤0.01% 1638
2025
Q1 		$59.4K Buy
1,020
+4
+0.4% +$273 ﹤0.01% 1535
2024
Q4 		$81.8K Buy
1,016
+439
+76% +$37.5K ﹤0.01% 1371
2024
Q3 		$46.2K Buy
577
+77
+15% +$5.47K ﹤0.01% 1673
2024
Q2 		$30.5K Buy
500
+20
+4% +$1.19K ﹤0.01% 1765
2024
Q1 		$23.7K Hold
480
– – ﹤0.01% 1890
2023
Q4 		$20.1K Buy
+480
New +$16.3K ﹤0.01% 1939

Other funds holding PRCT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return